Pembrolizumab for Early Triple-Negative Breast Cancer — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

Pembrolizumab for Early Triple-Negative Breast Cancer

PaperCitations, authors & open-access status

3,169

Citations

2,020

Year

bronze

OA Status

IDs:DOI PMID OpenAlex

Related on ScholarIQ

New England Journal of Medicine

Breast Cancer Treatment Studies

Breast Cancer Treatment Studies

Cancer Immunotherapy and Biomarkers